 MELBOURNE, Australia, April 09, 2021 GLOBE NEWSWIRE -- Genetic Technologies Limited ASX: GTG; NASDAQ: GENE, Company, GTG, a diversified Genomics and AI driven preventative health business provides an update to the market on the progress of the US commercial availability of the Companys COVID-19 Serious Disease Risk COVID-19 Risk Test via US Based Infinity BiologiX LLC IBX, ref: ASX Announcement 3 March 2021. 